Domainex in university collaboration on asthma

Collaboration

Drug discovery services specialist Domainex Ltd is to collaborate with St George’s University of London, and Manchester University, in the optimisation of inhibitors of Der p1, an enzyme that triggers asthma attacks. Cambridge-based Domainex will provide lead optimisation services.

Scientists led by Clive Robinson, professor of Respiratory Cell Science at St George’s, working in collaboration with David Garrod at Manchester and Domainex, have discovered various Der p1 inhibitors. They were recently awarded a £4 million research grant from the Wellcome Trust’s Seeding Drug Discovery Initiative to take the programme forward.